CVS Health (CVS)

• Market cap: $84.2B
• 1 day: 2.58%
• 5 days: 1.38%
• 1 month: -1.54%
• 3 months: 17.41%
• 6 months: 18.30%
• Year to date: 50.86%
• 1 year: -1.48%
• 5 years: 8.38%
• 10 years: -32.81%
• Sector: Healthcare
• Industry: Healthcare Plans

About: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.

Employees: 300,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

23% more call options, than puts

Call options by funds: $1.7B | Put options by funds: $1.38B

3.44% more ownership

Funds ownership: 79.76% [Q3] → 83.19% (+3.44%) [Q4]

10% less funds holding

Funds holding: 1,810 [Q3] → 1,623 (-187) [Q4]

25% less capital invested

Capital invested by funds: $63B [Q3] → $47.1B (-$15.9B) [Q4]

40% less first-time investments, than exits

New positions opened: 217 | Existing positions closed: 364

52% less funds holding in top 10

Funds holding in top 10: 27 [Q3] → 13 (-14) [Q4]

61% less repeat investments, than reductions

Existing positions increased: 360 | Existing positions reduced: 915

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $71 6% upside
• Avg. target: $76 13% upside
• High target: $82 23% upside

8 analyst ratings

• positive: 7 88%
• neutral: 1 13%
• negative: 0 0%

Baird Michael Ha 39% 1-year accuracy 9 / 23 met price target	6% upside $71	Neutral Maintained	15 Apr 2025
Truist Securities David Macdonald 54% 1-year accuracy 55 / 101 met price target	23% upside $82	Buy Maintained	11 Apr 2025
Mizuho Ann Hynes 57% 1-year accuracy 12 / 21 met price target	14% upside $76	Outperform Maintained	9 Apr 2025
Piper Sandler Jessica Tassan 26% 1-year accuracy 6 / 23 met price target	11% upside $74	Overweight Maintained	21 Mar 2025
JP Morgan Lisa Gill 63% 1-year accuracy 15 / 24 met price target	21% upside $81	Overweight Maintained	18 Feb 2025